A Boston-based nanotechnology incubator Nanobiosym developed a device and app to make the process of diagnosing a condition less costly and faster in a move that could shake up the diagnostic industry. It has been selected as the winner for the Nokia Sensing XCHALLENGE, according to a company statement.
Nanobiosym’s Gene Radar device can analyze a blood sample, saliva or other bodily fluid using a nanochip placed into a mobile device. It detects whether a pathogen is present or not in less than an hour. It doesn’t require running water or electricity to identify a pathogen’s presence, which makes it particularly useful for adoption in developing countries.
The company specializes in developing new technologies and spin-offs and joint ventures to solve unmet needs in global health, energy and the environment. So far, it has developed applications for E. coli and HIV.
NEMT Partner Guide: Why Payers and Providers Should Choose MediDrive’s TMS
Alan Murray on improving access for medical transportation.
It beat out 11 other finalists in the challenge. Robert K Weiss, the president of XPRIZE said the device met the objectives of the competition — “to advance innovative sensing technologies that will help transform healthcare into a ‘smart,’ highly personalized and instantly accessible system.”